The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
Open accessAbstract
Atherosclerosis is an immunoinflammatory pathological procedure in which lipid plaques are formed in the vessel walls, partially or completely occluding the lumen, and is accountable for atherosclerotic cardiovascular disease (ASCVD). ACSVD consists of three components: coronary artery disease (CAD), peripheral vascular disease (PAD) and cerebrovascular disease (CCVD). A disturbed lipid metabolism and the subsequent dyslipidemia significantly contribute to the formation of plaques, with low-density lipoprotein cholesterol (LDL-C) being the main responsible factor. Nonetheless, even when LDL-C is well regulated, mainly with statin therapy, a residual risk for CVD still occurs, and it is attributable to the disturbances of other lipid components, namely triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C). Increased plasma TG and decreased HDL-C levels have been associated with metabolic syndrome (MetS) and CVD, and their ratio, TG/HDL-C, has been proposed as a novel biomarker for predicting the risk of both clinical entities. Under these terms, this review will present and discuss the current scientific and clinical data linking the TG/HDL-C ratio with the presence of MetS and CVD, including CAD, PAD and CCVD, in an effort to prove the value of the TG/HDL-C ratio as a valuable predictor for each aspect of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Ray, K. K., Wright, R. S., Kallend, D., Koenig, W., Leiter, L. A., Raal, F. J., Bisch, J. A., Richardson, T., Jaros, M., Wijngaard, P. L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912387 · Cited by 1,665
Greenberg, S. M., Ziai, W. C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J. N., Hemphill, J. C., Johnson, R., Keigher, K. M., Mack, W. J., et al. (2022) · Stroke · doi:10.1161/str.0000000000000407 · Cited by 1,639
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Lloyd-Jones, D. M., Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Covington, A. M., DePalma, S. M., Minissian, M. B., Orringer, C. E., Smith, S. C., Waring, A. A., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.07.006 · Cited by 569
Sampson, U. K., Fazio, S., & Linton, M. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0219-7 · Cited by 439 · cited 1×
“Nevertheless, a noteworthy subset of patients remains in peril for CVD events, in spite of optimal LDL-C control [14].”
BackgroundHigh Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease
Luz, P. L. D., Favarato, D., Junior, J. R. F.-N., Lemos, P., & Chagas, A. C. P. (2008) · Clinics · doi:10.1590/s1807-59322008000400003 · Cited by 385
Lee, J. S., Chang, P.-Y., Zhang, Y., Kizer, J. R., Best, L. G., & Howard, B. V. (2017) · Diabetes Care · doi:10.2337/dc16-1958 · Cited by 325
Li, C., Ford, E. S., Meng, Y.-X., Mokdad, A. H., & Reaven, G. M. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-4 · Cited by 230
How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?
Welty, F. K. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0400-4 · Cited by 221
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
Dhindsa, D. S., Sandesara, P. B., Shapiro, M. D., & Wong, N. D. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00088 · Cited by 192
Gu, X., Li, Y., Chen, S., Yang, X., Liu, F., Li, Y., Li, J., Cao, J., Liu, X., Chen, J., et al. (2019) · Stroke · doi:10.1161/strokeaha.119.026402 · Cited by 161
Aday, A. W., Lawler, P. R., Cook, N. R., Ridker, P. M., Mora, S., & Pradhan, A. D. (2018) · Circulation · doi:10.1161/circulationaha.118.035432 · Cited by 143
Inflammation in Coronary Artery Disease
Christodoulidis, G., Vittorio, T. J., Fudim, M., Lerakis, S., & Kosmas, C. E. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000006 · Cited by 137
Self-citationBelete, R., Ataro, Z., Abdu, A., & Sheleme, M. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00641-8 · Cited by 136
Sultani, R., Tong, D. C., Peverelle, M., Lee, Y. S., Baradi, A., & Wilson, A. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.03.019 · Cited by 118
Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke
Kłoska, A., Malinowska, M., Gabig‐Cimińska, M., & Jakóbkiewicz‐Banecka, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103618 · Cited by 118
Inclisiran: a new promising agent in the management of hypercholesterolemia
Kosmas, C. E., Muñoz Estrella, A., Sourlas, A., Silverio, D., Hilario, E., Montan, P. D., & Guzman, E. (2018) · Diseases · doi:10.3390/diseases6030063 · Cited by 99
Cytokines in chronic respiratory diseases
Atamas, S. P., Chapoval, S. P., & Keegan, A. D. (2013) · F1000 Biology Reports · doi:10.3410/b5-3 · Cited by 91
Kosmas, C. E., Silverio, D., Tsomidou, C., Salcedo, M. D., Montan, P. D., & Guzman, E. (2018) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551418792257 · Cited by 74
Self-citationTG: HDL-C Ratio as Insulin Resistance Marker for Metabolic Syndrome in Children With Obesity
Iwani, A. K. N. Z., Jalaludin, M. Y., Yahya, A., Mansor, F., Zain, F. M., Hong, J. Y. H., Zin, R. M. W. M., & Mokhtar, A. H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.852290 · Cited by 65
Anti-inflammatory therapy for cardiovascular disease
Kosmas, C. E., Silverio, D., Sourlas, A., Montan, P. D., Guzman, E., & García, M. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.02.34 · Cited by 61
Self-citationNie, G., Hou, S., Zhang, M., & Peng, W. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041519 · Cited by 57
Deng, Q.-W., Li, S., Wang, H., Lei, L., Zhang, H., Gu, Z., Xing, F., & Yan, F. (2018) · Aging and Disease · doi:10.14336/ad.2017.0629 · Cited by 54
Colesterol LDL y aterosclerosis: evidencias
Guijarro, C., & Cosín-Sales, J. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.12.004 · Cited by 54
Wakabayashi, I., & Daimon, T. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1098-0 · Cited by 52
Prasad, M., Sara, J. D. S., Widmer, R. J., Lennon, R. J., Lerman, L. O., & Lerman, A. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.009442 · Cited by 50
Allawi, A. A. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.09.003 · Cited by 47
Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease
Kou, M., Ding, N., Ballew, S. H., Salameh, M., Martin, S. S., Selvin, E., HEISS, G. M., Ballantyne, C. M., Matsushita, K., & Hoogeveen, R. C. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315828 · Cited by 44
How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL
Averna, M. R., Stroes, E. S. G., Ogura, M., Postadzhiyan, A., Čerček, M., Calabrò, P., & Suppressa, P. (2017) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(17)30021-1 · Cited by 42
Prognostic significance of major lipids in patients with acute ischemic stroke
Τζιόμαλος, Κ., Giampatzis, V., Bouziana, S. D., Spanou, M., Kostaki, S., Papadopoulou, M., Angelopoulou, S.-M., Tsopozidi, M., Savopoulos, C. G., & Hatzitolios, A. I. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9924-9 · Cited by 41
Li, X., Li, X., Fang, F., Fu, X., Lin, H., & Gao, Q. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.03.014 · Cited by 41
Yokoyama, K., Tani, S., Matsuo, R., & Matsumoto, N. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1247-9 · Cited by 41
O'Donnell, M. J., McQueen, M., Sniderman, A. D., Paré, G., Wang, X., Hankey, G. J., Rangarajan, S., Chin, S. L., Ps, R., Ferguson, J. P., et al. (2022) · Journal of Stroke · doi:10.5853/jos.2021.02152 · Cited by 41
Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL
Marston, N. A., Giugliano, R. P., Park, J.-G., Ruzza, A., Sever, P. S., Keech, A. C., & Sabatine, M. S. (2021) · Circulation · doi:10.1161/circulationaha.121.056536 · Cited by 38
Nam, K., Kwon, H., Jeong, H., Park, J., Kwon, H., & Jeong, S. (2019) · BMC Neurology · doi:10.1186/s12883-019-1373-8 · Cited by 35
Mardi, P., Abdi, F., Ehsani, A., Seif, E., Djalalinia, S., Heshmati, J., Shahrestanaki, E., Gorabi, A. M., & Qorbani, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.957136 · Cited by 32
Lelis, D. D. F., Calzavara, J. V. S., Santos, R. D., Sposito, A. C., Griep, R. H., Barreto, S. M., Molina, M. D. C. B., Schmidt, M. I., Duncan, B. B., Benseñor, I. M., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.07.005 · Cited by 31
Shao, Q., Ma, X., Yang, Z., Li, Q.-X., Wang, Y., Liang, J., Shen, H., Liu, X., Zhou, Y., Shi, D., et al. (2022) · PubMed Central · doi:10.11909/j.issn.1671-5411.2022.06.001 · Cited by 29
Shin, H.-G., Kim, Y.-K., Kim, Y., Jung, Y.-H., & Kang, H. (2017) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2017.38.6.352 · Cited by 28
Deng, Q.-W., Liu, Y., Zhang, Y., Chen, X., Jiang, T., Hou, J., Shi, H., Lü, M., Zhou, F., Wang, W., et al. (2019) · Aging · doi:10.18632/aging.101859 · Cited by 26
Ding, C., Chen, Y., Shi, Y., Li, M., Hu, L., Zhou, W., Wang, T., Zhu, L., Huang, X. B., Bao, H., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01407-3 · Cited by 25
Is it possible to predict the complexity of peripheral artery disease with atherogenic index?
Engin, M., Aydın, C., & Güvenç, O. (2020) · Vascular · doi:10.1177/1708538120923531 · Cited by 24
Woo, M.-H., Lee, K. O., Chung, D., Choi, J.-W., Kim, S.-H., & Oh, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.504219 · Cited by 24
Nosrati, M., Safari, M., Alizadeh, A., Ahmadi, M., & Mahrooz, A. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_357_20 · Cited by 23
Zhan, X., Yang, M. L., Zhou, R., Wei, X., Chen, Y., & Chen, Q. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1147-8 · Cited by 21
Lipid ratio as a suitable tool to identify individuals with MetS risk: A case- control study
Abbasian, M., Delvarianzadeh, M., Ebrahimi, H., & Khosravi, F. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.011 · Cited by 20
Kundi, H., Korkmaz, A., Balun, A., Çiçekçioğlu, H., Kızıltunç, E., Gürsel, K., Çetın, M., Örnek, E., & İleri, M. (2017) · Angiology · doi:10.1177/0003319716689366 · Cited by 18
Triglyceride to High-Density Lipoprotein Ratio can predict coronary artery calcification
Wang, B., Hua, J., & Ma, L. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.3.5290 · Cited by 17
Tsai, S. X., & Vega, G. L. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001252 · Cited by 15
Conkbayır, C., Ayça, B., & Ökçün, E. Ö. B. (2015) · PubMed Central · Cited by 14
Gharipour, M., Sadeghi, M., Nezafati, P., Dianatkhah, M., & Sarrafzadegan, N. (2019) · PubMed Central · Cited by 14
Matsumoto, I., Misaki, A., Kurozumi, M., Nanba, T., & Takagi, Y. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.07.012 · Cited by 12
The association of blood lipid parameters variability with ischemic stroke in hypertensive patients
Huang, Y., Liu, L., Liu, X., Lo, K. K.-H., Tang, S.-T., Feng, Y., & Zhang, B. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.02.004 · Cited by 12
Arterial function parameters in patients with metabolic syndrome and severe hypertriglyceridemia
Rinkūnienė, E., Butkutė, E., Puronaitė, R., Petrulionienė, Ž., Dzenkeviciute, V., Kasiulevičius, V., & Laucevičius, A. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.04.119 · Cited by 9
Is Triglyceride/HDL Be A Predictor Of Young Stroke Vascular Risk?
Çoban, E. (2018) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2018.83097 · Cited by 8
Unraveling the Risk of Peripheral Artery Disease
Joshi, P. H., & Martin, S. S. (2018) · Circulation · doi:10.1161/circulationaha.118.036347 · Cited by 8
Metadata
- Authors
- Kosmas, C. E., Rodriguez Polanco, S., Bousvarou, M. D., Papakonstantinou, E. J., Peña Genao, E., Guzman, E., & Kostara, C. E.
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2023-03-01
- Volume
- 13
- Issue
- 5
- Pages
- 929
- ISSN
- 2075-4418 (ISSN-L)
- OpenAlex
- W4322774851
- Cited by
- 320
- References
- 60
- FWCI
- 52.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.